Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis

Tim Bauer, Heleen J. Bouman, Jochem W. van Werkum, Neville F. Ford, Jurrien M Ten Berg, Dirk Taubert^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{be85ea45da694a6883a65161963f06d6,

title = "Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis",

author = "Tim Bauer and Bouman, {Heleen J.} and {van Werkum}, {Jochem W.} and Ford, {Neville F.} and {Ten Berg}, {Jurrien M} and Dirk Taubert",

year = "2011",

month = aug,

day = "4",

doi = "10.1136/bmj.d4588",

language = "English",

volume = "343",

pages = "18",

journal = "BMJ (e)",

issn = "1756-1833",

publisher = "BMJ Publishing Group",

}

In: BMJ (e), Vol. 343, 04.08.2011, p. 18.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis

AU - Bauer, Tim

AU - Bouman, Heleen J.

AU - van Werkum, Jochem W.

AU - Ford, Neville F.

AU - Ten Berg, Jurrien M

AU - Taubert, Dirk

PY - 2011/8/4

Y1 - 2011/8/4

U2 - 10.1136/bmj.d4588

DO - 10.1136/bmj.d4588

M3 - Article

C2 - 21816733

VL - 343

SP - 18

JO - BMJ (e)

JF - BMJ (e)

SN - 1756-1833

ER -